Marked enhancement of interferon production in 5-bromodeoxyuridine treated human lymphoblastoid cells.
D001402:B-Lymphocytes / Q000378:metabolism / Q000382:microbiology; D001973:Bromodeoxyuridine / Q000378:metabolism / Q000494:pharmacology*; D002460:Cell Line; D004247:DNA / Q000378:metabolism; D004854:Herpesvirus 4, Human / Q000254:growth & development*; D007372:Interferons / Q000096:biosynthesis*; D008214:Lymphocytes / Q000378:metabolism* / Q000382:microbiology; D009522:Newcastle disease virus; D013601:T-Lymphocytes / Q000378:metabolism / Q000382:microbiology; D014779:Virus Replication / Q000187:drug effects
D004247:DNA; D007372:Interferons; D001973:Bromodeoxyuridine